What is the price of United health care stock?
Similar to UnitedHealth Group, other healthcare providers such as Humana Inc. HUM, Molina Healthcare, Inc. MOH and Cigna Corporation CI boast solid membership growth and have been awarded contracts from various states from time to time. Centene makes use ...
Why did United Healthcare stock drop?
The insurance company said that it saw intense price competition in several markets, including New York, in the quarter. UnitedHealth said competitors are pricing coverage below cost to attract customers, which could hurt its enrollment numbers.
What are the top healthcare stocks?
Risks of Investing in Healthcare Stocks
- The rising costs of U.S. healthcare appear unsustainable. ...
- Disruption by new players is a constant threat for established healthcare stocks. More and more tech companies are getting involved in the healthcare sector. ...
- Sustaining growth can be challenging for some types of healthcare stocks. ...
What is the ticker symbol for United health care?
UnitedHealth Group Incorporated Common Stock (DE) (UNH) Nasdaq Listed. Nasdaq 100. $334.00. +0.42 (+0.13%) CLOSED AT 4:00 PM ET ON Feb 01, 2021. Data is currently not available. $332.79.
See more
Is UnitedHealthcare a good stock to buy?
The financial health and growth prospects of UNH, demonstrate its potential to outperform the market. It currently has a Growth Score of B. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of B.
Is UnitedHealth a dividend aristocrat?
UnitedHealth is not a Dividend King, Dividend Aristocrat, or Dividend Champion. The dividend has only been growing for the past 11 years making this stock a Dividend Contender. Furthermore, the dividend yield is only ~1.7% and so this stock does not pass the screens of investors seeking income.
Why did UNH go down?
Earnings from operations worth $396 million were down 81.1% year over year due to the impact of higher COVID-19 testing and care costs, partially mitigated by higher revenues.
Who owns UHC stock?
Top 10 Owners of UnitedHealth Group IncStockholderStakeShares ownedThe Vanguard Group, Inc.8.20%76,924,734SSgA Funds Management, Inc.4.93%46,274,771Fidelity Management & Research Co...4.76%44,675,718BlackRock Fund Advisors4.35%40,833,7156 more rows
When was the last time United Healthcare stock split?
UnitedHealth's last stock split was in 2005 However, there have been no splits since then.
Is UNH a good dividend stock?
UnitedHealth Group's Dividend Is Well Covered By Earnings Looking forward, earnings per share is forecast to rise by 16.3% over the next year. If the dividend continues on this path, the payout ratio could be 33% by next year, which we think can be pretty sustainable going forward.
What is optum stock symbol?
Stock market history UnitedHealth Group (OPTUMHEALTH)XPriceApr 21, 2022537.44Apr 20, 2022546.01Apr 19, 2022537.7Apr 18, 2022534.08215 more rows
Who owns optum?
UnitedHealth GroupOptum / Parent organizationOptumCare, a part of the Optum subsidiary of UnitedHealth Group (UHG), provides data driven, integrated direct-to-patient care including physicians, home health, urgent care and surgical care totaling over $15 billion of revenue in 2016.
Is United Healthcare publicly traded?
UnitedHealth Group's common stock is traded on the New York Stock Exchange (NYSE) under the symbol UNH.
Is AARP owned by UnitedHealthcare?
AARP® Medicare Supplement insurance plans for retirees. UnitedHealthcare Insurance Company (UnitedHealthcare) is the exclusive insurer of AARP Medicare Supplement insurance plans.
Is Uhg a Fortune 500 company?
Fortune magazine ranked UnitedHealth Group No. 5 in the 2021 rankings of the 500 largest U.S. corporations based on 2020 revenues. Fortune magazine ranked UnitedHealth Group No. 8 on its 2021 Global 500, a list of the world's largest corporations based on 2020 revenues.
Is Optum a Fortune 500 company?
Optum - In fortune 500 ranked at 6th company.
What is UnitedHealth Group?
What is OptumRx?
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated has partnership with the University of California, San Francisco to expand the mental health workforce in California. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
Transparency is our policy. Learn how it impacts everything we do
The OptumRx segment provides pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minnetonka, MN. Read More.
How we make money
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
How we use your personal data
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.
How we approach editorial content
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
Who is UHP?
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view.
What is UHP oxidized cellulose?
United Health Products, Inc. (OTC: UEEC), ("UHP" or the "Company"), developer, manufacturer and marketer of HemoStyp®, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent, today announced the appointment of John Phillips to the newly created position of Vice President, Marketing & Commercial Strategy, ...
Is hemostyp a regenerated cellulose?
United Health Products, Inc. (OTC: UEEC) ("UHP" or the "Company"), today announced that it has filed a non-provisional patent application with the U.S. Patent & Trademark Office for the hydrocolloid (gel) format of its HemoStyp oxidized regenerated cellulose product, and has also filed a separate application under the Patent Cooperation Treaty with the World Intellectual Property Organization. The Patent Cooperation Treaty (PCT) is an international patent law treaty which provides a unified procedure for filing of a patent application in the majority of foreign countries. The Company previously filed a provisional patent application for the hydrocolloid technology in July 2019.
New York Stock Exchange
United Health Products, Inc. (OTC: UEEC) ("UHP" or the "Company"), developer, manufacturer and marketer of HemoStyp, a patented Oxidized Regenerated Cellulose (ORC), today announced that the Journal of Wound Care, headquartered in London, England, has informed the Company that UHP’s submitted article, Efficacy and Safety of HemoStyp as an Adjunct for Management of Secondary Hemostasis in the Operative Setting, has been accepted for publication in the November 2020 edition. This article, which was peer reviewed, was authored by Raymond Schaerf, MD, Sasan Najibi, MD, John Conrad, MD, and Gerard Abate, MD. This journal submission highlights the results of the study showing HemoStyp’s superiority to Surgicel®, an Ethicon Inc. product, a division of Johnson & Johnson.
Environmental, Social, and Governance Rating
A health insurance giant, UnitedHealth Group serves more than 75 million people worldwide.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
Ownership
- UnitedHealth Group trades on the New York Stock Exchange (NYSE) under the ticker symbol \"UNH.\" UnitedHealth Group's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.35%), Wells Fargo & Company MN (0.77%), Janus Henderson Group PLC (0.58%), Sumitomo Mitsui Trust Holdings Inc. (0.43%), Parametric …
Results
- UnitedHealth Group Inc (NYSE:UNH) issued its quarterly earnings results on Tuesday, April, 16th. The healthcare conglomerate reported $3.73 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $3.60 by $0.13. The healthcare conglomerate had revenue of $60.30 billion for the quarter, compared to analysts' expectations of $59.72 billion. UnitedHealth …
Release
- UnitedHealth Group is scheduled to release their next quarterly earnings announcement on Tuesday, July 16th 2019. View Earnings Estimates for UnitedHealth Group.
Risks
- 20 analysts have issued 1-year price objectives for UnitedHealth Group's stock. Their predictions range from $238.00 to $312.00. On average, they anticipate UnitedHealth Group's share price to reach $292.2778 in the next year. This suggests a possible upside of 21.5% from the stock's current price. View Analyst Price Targets for UnitedHealth Group.
Ratings
- 20 Wall Street analysts have issued \"buy,\" \"hold,\" and \"sell\" ratings for UnitedHealth Group in the last year. There are currently 1 hold rating, 18 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of \"Buy.\" View Analyst Ratings for UnitedHealth Group. News articles about UNH stock have been trending somewhat positive on Saturday, acco…
Business
- UnitedHealth Group has a market capitalization of $228.64 billion and generates $226.25 billion in revenue each year. The healthcare conglomerate earns $11.99 billion in net income (profit) each year or $12.88 on an earnings per share basis. UnitedHealth Group employs 300,000 workers across the globe.
Infrastructure
- UnitedHealth Group's mailing address is 9900 BREN ROAD EAST, MINNETONKA MN, 55343. The healthcare conglomerate can be reached via phone at 952-936-1300 or via email at [email protected].